IDEAS home Printed from https://ideas.repec.org/a/nat/nathum/v6y2022i2d10.1038_s41562-022-01289-8.html
   My bibliography  Save this article

Equitable access to COVID-19 vaccines makes a life-saving difference to all countries

Author

Listed:
  • Yang Ye

    (City University of Hong Kong)

  • Qingpeng Zhang

    (City University of Hong Kong)

  • Xuan Wei

    (Shanghai Jiao Tong University)

  • Zhidong Cao

    (Chinese Academy of Sciences
    University of Chinese Academy of Sciences)

  • Hsiang-Yu Yuan

    (City University of Hong Kong
    City University of Hong Kong)

  • Daniel Dajun Zeng

    (Chinese Academy of Sciences
    University of Chinese Academy of Sciences)

Abstract

Despite broad agreement on the negative consequences of vaccine inequity, the distribution of COVID-19 vaccines is imbalanced. Access to vaccines in high-income countries (HICs) is far greater than in low- and middle-income countries (LMICs). As a result, there continue to be high rates of COVID-19 infections and deaths in LMICs. In addition, recent mutant COVID-19 outbreaks may counteract advances in epidemic control and economic recovery in HICs. To explore the consequences of vaccine (in)equity in the face of evolving COVID-19 strains, we examine vaccine allocation strategies using a multistrain metapopulation model. Our results show that vaccine inequity provides only limited and short-term benefits to HICs. Sharper disparities in vaccine allocation between HICs and LMICs lead to earlier and larger outbreaks of new waves. Equitable vaccine allocation strategies, in contrast, substantially curb the spread of new strains. For HICs, making immediate and generous vaccine donations to LMICs is a practical pathway to protect everyone.

Suggested Citation

  • Yang Ye & Qingpeng Zhang & Xuan Wei & Zhidong Cao & Hsiang-Yu Yuan & Daniel Dajun Zeng, 2022. "Equitable access to COVID-19 vaccines makes a life-saving difference to all countries," Nature Human Behaviour, Nature, vol. 6(2), pages 207-216, February.
    • Handle: RePEc:nat:nathum:v:6:y:2022:i:2:d:10.1038_s41562-022-01289-8
    DOI: 10.1038/s41562-022-01289-8
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41562-022-01289-8
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/s41562-022-01289-8?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Muhammed A. Yildirim & Cem Cakmakli & Selva Demiralp & Sebnem Kalemli-Ozcan & Sevcan Yesiltas, 2021. "The Economic Case for Global Vaccinations: An Epidemiological Model with International Production Networks," CID Working Papers 390, Center for International Development at Harvard University.
    2. Edouard Mathieu & Hannah Ritchie & Esteban Ortiz-Ospina & Max Roser & Joe Hasell & Cameron Appel & Charlie Giattino & Lucas Rodés-Guirao, 2021. "A global database of COVID-19 vaccinations," Nature Human Behaviour, Nature, vol. 5(7), pages 947-953, July.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Dimitris Zavras, 2022. "Access to the COVID-19 Vaccine," IJERPH, MDPI, vol. 19(17), pages 1-4, September.
    2. Rughinis, Cosima & Vulpe, Simona Nicoleta & Flaherty, Michael G. & Vasile, Sorina, 2022. "Vaccination, life expectancy, and trust: Patterns of COVID-19 vaccination rates around the world," MPRA Paper 111981, University Library of Munich, Germany.
    3. Michele Tizzoni & Elaine O. Nsoesie & Laetitia Gauvin & Márton Karsai & Nicola Perra & Shweta Bansal, 2022. "Addressing the socioeconomic divide in computational modeling for infectious diseases," Nature Communications, Nature, vol. 13(1), pages 1-7, December.
    4. Anderson F. Brito & Elizaveta Semenova & Gytis Dudas & Gabriel W. Hassler & Chaney C. Kalinich & Moritz U. G. Kraemer & Joses Ho & Houriiyah Tegally & George Githinji & Charles N. Agoti & Lucy E. Matk, 2022. "Global disparities in SARS-CoV-2 genomic surveillance," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    5. Nicolò Gozzi & Matteo Chinazzi & Natalie E. Dean & Ira M. Longini Jr & M. Elizabeth Halloran & Nicola Perra & Alessandro Vespignani, 2023. "Estimating the impact of COVID-19 vaccine inequities: a modeling study," Nature Communications, Nature, vol. 14(1), pages 1-10, December.
    6. Chuanlin Ning & Han Wang & Jing Wu & Qinwei Chen & Huacheng Pei & Hao Gao, 2022. "The COVID-19 Vaccination and Vaccine Inequity Worldwide: An Empirical Study Based on Global Data," IJERPH, MDPI, vol. 19(9), pages 1-13, April.
    7. Sahabi Kabir Sulaiman & Muhammad Sale Musa & Fatimah Isma’il Tsiga-Ahmed & Abdulwahab Kabir Sulaiman & Abdulaziz Tijjani Bako, 2024. "A systematic review and meta-analysis of the global prevalence and determinants of COVID-19 vaccine acceptance and uptake in people living with HIV," Nature Human Behaviour, Nature, vol. 8(1), pages 100-114, January.
    8. Muckstadt, John A. & Klein, Michael G. & Jackson, Peter L. & Gougelet, Robert M. & Hupert, Nathaniel, 2023. "Efficient and effective large-scale vaccine distribution," International Journal of Production Economics, Elsevier, vol. 262(C).

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. S. D. Sreeganga & Ajay Chandra & Arkalgud Ramaprasad, 2021. "Ontological Analysis of COVID-19 Vaccine Roll out Strategies: A Comparison of India and the United States of America," IJERPH, MDPI, vol. 18(14), pages 1-18, July.
    2. Linus Nyiwul, 2021. "Epidemic Control and Resource Allocation: Approaches and Implications for the Management of COVID-19," Studies in Microeconomics, , vol. 9(2), pages 283-305, December.
    3. D. G. Webster & Semra A. Aytur & Mark Axelrod & Robyn S. Wilson & Joseph A. Hamm & Linda Sayed & Amber L. Pearson & Pedro Henrique C. Torres & Alero Akporiaye & Oran Young, 2022. "Learning from the Past: Pandemics and the Governance Treadmill," Sustainability, MDPI, vol. 14(6), pages 1-26, March.
    4. Ilias Chronopoulos & Katerina Chrysikou & George Kapetanios & James Mitchell & Aristeidis Raftapostolos, 2023. "Deep Neural Network Estimation in Panel Data Models," Working Papers 23-15, Federal Reserve Bank of Cleveland.
    5. Jo Daniels & Hannah Rettie, 2022. "The Mental Health Impact of the COVID-19 Pandemic Second Wave on Shielders and Their Family Members," IJERPH, MDPI, vol. 19(12), pages 1-17, June.
    6. Bonadio, Barthélémy & Huo, Zhen & Levchenko, Andrei A. & Pandalai-Nayar, Nitya, 2021. "Global supply chains in the pandemic," Journal of International Economics, Elsevier, vol. 133(C).
    7. Jiang, Peng & Klemeš, Jiří Jaromír & Fan, Yee Van & Fu, Xiuju & Tan, Raymond R. & You, Siming & Foley, Aoife M., 2021. "Energy, environmental, economic and social equity (4E) pressures of COVID-19 vaccination mismanagement: A global perspective," Energy, Elsevier, vol. 235(C).
    8. Emily Cameron-Blake & Helen Tatlow & Bernardo Andretti & Thomas Boby & Kaitlyn Green & Thomas Hale & Anna Petherick & Toby Phillips & Annalena Pott & Adam Wade & Hao Zha, 2023. "A panel dataset of COVID-19 vaccination policies in 185 countries," Nature Human Behaviour, Nature, vol. 7(8), pages 1402-1413, August.
    9. John Gibson, 2023. "Jabbing the economy back to life?," Applied Economics Letters, Taylor & Francis Journals, vol. 30(21), pages 2999-3005, December.
    10. Simon Munzert & Sebastian Ramirez-Ruiz & Başak Çalı & Lukas F. Stoetzer & Anita Gohdes & Will Lowe, 2022. "Prioritization preferences for COVID-19 vaccination are consistent across five countries," Palgrave Communications, Palgrave Macmillan, vol. 9(1), pages 1-10, December.
    11. de León, Ugo Avila-Ponce & Avila-Vales, Eric & Huang, Kuan-lin, 2022. "Modeling COVID-19 dynamic using a two-strain model with vaccination," Chaos, Solitons & Fractals, Elsevier, vol. 157(C).
    12. Santiago Justo Arevalo & Carmen Sofia Uribe Calampa & Cinthy Jimenez Silva & Mauro Quiñones Aguilar & Remco Bouckaert & Joao Renato Rebello Pinho, 2023. "Phylodynamic of SARS-CoV-2 during the second wave of COVID-19 in Peru," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    13. L'aszl'o Czaller & GergH{o} T'oth & Bal'azs Lengyel, 2021. "Vaccine allocation to blue-collar workers," Papers 2104.04639, arXiv.org.
    14. Keser, Claudia & Rau, Holger A., 2022. "Policy incentives and determinants of citizens' COVID-19 vaccination motives," University of Göttingen Working Papers in Economics 434, University of Goettingen, Department of Economics.
    15. Caixia Wang & Huijie Li, 2023. "Variation in Global Policy Responses to COVID-19: A Bidirectional Analysis," IJERPH, MDPI, vol. 20(5), pages 1-13, February.
    16. The PLOS Medicine Editors, 2022. "Vaccine equity: A fundamental imperative in the fight against COVID-19," PLOS Medicine, Public Library of Science, vol. 19(2), pages 1-4, February.
    17. Ricardo Hausmann & Ulrich Schetter & Muhammed A. Yildirim, 2022. "On the Design of Effective Sanctions: The Case of Bans on Exports to Russia," CID Working Papers 417, Center for International Development at Harvard University.
    18. Juan Pablo Gutiérrez-Jara & Chiara Saracini, 2022. "Risk Perception Influence on Vaccination Program on COVID-19 in Chile: A Mathematical Model," IJERPH, MDPI, vol. 19(4), pages 1-12, February.
    19. Krueger, Rico & Daziano, Ricardo A., 2022. "Stated choice analysis of preferences for COVID-19 vaccines using the Choquet integral," Journal of choice modelling, Elsevier, vol. 45(C).
    20. Clarke, Philip & Loewen, Peter & Bonnefon, Jean-François & Melegaro, Alessia & Friedman, Jorge & Violato, Mara & Barnett, Adrian & Duch, Raymond & Roope, Laurence, 2021. "Public opinion on global rollout of COVID-19 vaccines," TSE Working Papers 21-1214, Toulouse School of Economics (TSE).

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nathum:v:6:y:2022:i:2:d:10.1038_s41562-022-01289-8. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.